Treatment of Thrush (Oral and Vaginal Candidiasis)
For oral thrush with mild disease, use clotrimazole troches 10 mg five times daily for 7-14 days, and for moderate to severe oral thrush, use oral fluconazole 100-200 mg daily for 7-14 days. 1 For uncomplicated vaginal candidiasis, either a single 150 mg dose of oral fluconazole or any topical azole antifungal (clotrimazole, miconazole, terconazole) for 1-7 days depending on formulation are equally effective. 2
Oral Candidiasis (Oral Thrush)
Mild Disease
- Clotrimazole troches 10 mg five times daily for 7-14 days 1
- Alternative: Miconazole mucoadhesive buccal 50-mg tablet applied to mucosal surface over canine fossa once daily for 7-14 days 1
- Alternative: Nystatin suspension (100,000 U/mL) 4-6 mL four times daily, OR 1-2 nystatin pastilles (200,000 U each) four times daily for 7-14 days 1
Moderate to Severe Disease
- Oral fluconazole 100-200 mg daily for 7-14 days 1
- This is the preferred treatment for more symptomatic presentations
Fluconazole-Refractory Disease
If symptoms persist despite fluconazole treatment:
- Itraconazole solution 200 mg once daily OR posaconazole suspension 400 mg twice daily for 3 days, then 400 mg daily for up to 28 days 1
- Alternative: Voriconazole 200 mg twice daily OR amphotericin B deoxycholate oral suspension 100 mg/mL four times daily 1
- For truly refractory cases: IV echinocandin (caspofungin 70-mg loading dose, then 50 mg daily; micafungin 100 mg daily; or anidulafungin 200-mg loading dose, then 100 mg daily) 1
Special Considerations
- Denture-related candidiasis requires disinfection of the denture in addition to antifungal therapy 1
- For HIV-infected patients, antiretroviral therapy is strongly recommended to reduce recurrent infections 1
- Chronic suppressive therapy is usually unnecessary, but if recurrent infections occur, fluconazole 100 mg three times weekly can be used 1
Vaginal Candidiasis (Vaginal Thrush)
Uncomplicated Vulvovaginal Candidiasis (90% of cases)
Single-dose oral therapy:
Topical intravaginal options (all equally effective):
- Clotrimazole 1% cream 5 g intravaginally for 7-14 days 3
- Clotrimazole 2% cream 5 g intravaginally for 3 days 3
- Miconazole 2% cream 5 g intravaginally for 7 days 3
- Miconazole 4% cream 5 g intravaginally for 3 days 3
- Miconazole 200 mg suppository for 3 days 3
- Terconazole 0.4% cream 5 g intravaginally for 7 days 3
- Terconazole 0.8% cream 5 g intravaginally for 3 days 3
The choice between oral and topical therapy should be based on patient preference, as efficacy is equivalent. 2
Complicated Vulvovaginal Candidiasis (10% of cases)
Defined as: severe symptoms, recurrent disease (≥4 episodes/year), non-albicans species, or abnormal host (diabetes, immunosuppression, pregnancy)
Recurrent Vulvovaginal Candidiasis (≥4 episodes/year)
Induction phase:
- 10-14 days of topical or oral azole therapy 2
Maintenance phase:
- Fluconazole 150 mg once weekly for 6 months 2, 4
- Note: 50% of patients relapse after stopping maintenance therapy, so consider longer-term suppression in some cases 5
Non-Albicans Species
For C. glabrata (fluconazole-resistant):
- Boric acid 600 mg vaginal suppository daily for 14 days 2
- Alternative: Topical flucytosine cream (must be compounded) 2
- Alternative: High-dose fluconazole 800 mg daily for 2-3 weeks (though resistance is common) 5
For C. krusei (triazole-resistant):
- Amphotericin B deoxycholate 0.3-0.6 mg/kg daily 1
Common Pitfalls and Caveats
Diagnostic accuracy: Less than 50% of women who self-diagnose and treat for vaginal candidiasis actually have the condition. 3 Confirmation with microscopy, pH testing (should be <4.5), or culture is recommended before treatment when possible.
Pregnancy considerations:
- For oral thrush: Topical agents are preferred; avoid systemic azoles
- For vaginal candidiasis: Only topical azole therapy should be used; oral fluconazole is contraindicated 3
- Treatment in third trimester may reduce neonatal oral thrush and diaper dermatitis 5
Partner treatment: Male sexual partners do not require treatment unless symptomatic 6
Resistance patterns: Azole-resistant C. albicans is extremely rare in vaginal candidiasis but more common in oral candidiasis, particularly in HIV-infected patients 2
Treatment failure: If symptoms persist after appropriate therapy, consider non-albicans species, reinfection, incorrect diagnosis (bacterial vaginosis, trichomoniasis, contact dermatitis), or rarely, true azole resistance requiring culture and susceptibility testing 3